Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.

©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR ...

All Of It with Alison Stewart is a show about culture and its consumers. ALL OF IT is a show about culture and context. ALL OF IT is a show about culture and the culture. Our aim is to engage the ...

From KMUW Studios and part of the NPR Podcast Network, You're Saying It Wrong is a podcast that looks at what we get wrong—and what we sometimes get right—when it comes to this English language.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Ratnakar Lavu, Elevance Health's chief digital information officer, discusses how the seventh largest healthcare company based on revenue shares validates AI models.

A global leader in safety and industrial technology is expanding its IoT and cloud platform capabilities, building cutting-edge solutions that connect HVAC-R systems, gas detection hardware, and OEM ...